---
title: "Hvsen Biotech: Net loss of 20.1556 million yuan in 2024, turning from profit to loss"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/237827071.md"
description: "Hvsen Biotech announced that the operating revenue for 2024 is expected to be 1.2 billion yuan, a year-on-year increase of 17.71%. The net loss attributable to shareholders of the listed company is 20.1556 million yuan, compared to a net profit of 16.7808 million yuan in the same period last year, marking a shift from profit to loss. The profit distribution plan approved by the company's board of directors is as follows: based on a total share capital of 166 million shares as of December 31, 2024, excluding 753,600 shares held in the repurchase special securities account, the total share capital is 165 million shares. A cash dividend of 1.3 yuan will be distributed for every 10 shares to all shareholders, with no bonus shares issued, and no shares will be converted from capital reserve to all shareholders for every 10 shares"
datetime: "2025-04-28T11:03:23.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/237827071.md)
  - [en](https://longbridge.com/en/news/237827071.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/237827071.md)
generator: "portal-rs"
---

# Hvsen Biotech: Net loss of 20.1556 million yuan in 2024, turning from profit to loss

Hvsen Biotech announced that the operating revenue for 2024 is expected to be 1.2 billion yuan, a year-on-year increase of 17.71%. The net loss attributable to shareholders of the listed company is 20.1556 million yuan, compared to a net profit of 16.7808 million yuan in the same period last year, resulting in a loss from profit. The profit distribution plan approved by the board of directors is as follows: based on the total share capital of 166 million shares as of December 31, 2024, excluding 753,600 shares held in the repurchase special securities account, a cash dividend of 1.3 yuan will be distributed for every 10 shares to all shareholders, with 0 bonus shares, and a transfer of 0 shares from the capital reserve for every 10 shares to all shareholders

### Related Stocks

- [300871.CN](https://longbridge.com/en/quote/300871.CN.md)

## Related News & Research

- [Nivika acquires warehouse, light industrial properties in Jönköping and Halmstad for SEK 66 million](https://longbridge.com/en/news/298034197.md)
- [Banca Agricola Popolare di Sicilia suspends liquidity support for BAPS shares on Vorvel Equity Auction](https://longbridge.com/en/news/297940680.md)
- [Smartwell Showcases AI-Driven Strawberry Cultivation Through Its Commercially Deployed Smart Agriculture Platform](https://longbridge.com/en/news/297950067.md)
- [Align Capital’s Marco Sealing Solutions acquires Global O-Ring and Seal](https://longbridge.com/en/news/297905587.md)
- [Biohit says scientific review backs serum biomarker triage to target endoscopy for gastric cancer risk](https://longbridge.com/en/news/297887371.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**